| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2369 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1807 | 2018 |
| Epidemiology and natural history of HCV infection B Hajarizadeh, J Grebely, GJ Dore Nature reviews Gastroenterology & hepatology 10 (9), 553-562, 2013 | 1398 | 2013 |
| Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ... The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022 | 661 | 2022 |
| Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression R Waziry, B Hajarizadeh, J Grebely, J Amin, M Law, M Danta, J George, ... Journal of hepatology 67 (6), 1204-1212, 2017 | 598 | 2017 |
| The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection J Grebely, K Page, R Sacks‐Davis, MS van der Loeff, TM Rice, J Bruneau, ... Hepatology 59 (1), 109-120, 2014 | 545 | 2014 |
| Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study D Razavi-Shearer, I Gamkrelidze, C Pan, J Jia, T Berg, R Gray, YS Lim, ... The lancet Gastroenterology & hepatology 8 (10), 879-907, 2023 | 359 | 2023 |
| Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial J Grebely, O Dalgard, B Conway, EB Cunningham, P Bruggmann, ... The lancet Gastroenterology & hepatology 3 (3), 153-161, 2018 | 348 | 2018 |
| Hepatitis B Virus infection in Iran: A systematic review. SM Alavian, B Hajarizadeh, M Ahmadzad-Asl, A Kabir, ... Hepatitis monthly 8 (4), 2008 | 276 | 2008 |
| Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review L Degenhardt, P Webb, S Colledge-Frisby, J Ireland, A Wheeler, ... The lancet global health 11 (5), e659-e672, 2023 | 251 | 2023 |
| Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis B Hajarizadeh, EB Cunningham, H Reid, M Law, GJ Dore, J Grebely The lancet Gastroenterology & hepatology 3 (11), 754-767, 2018 | 251 | 2018 |
| Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: a systematic review S Bajis, GJ Dore, B Hajarizadeh, EB Cunningham, L Maher, J Grebely International Journal of Drug Policy 47, 34-46, 2017 | 245 | 2017 |
| Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: a meta-analysis B Hajarizadeh, EB Cunningham, H Valerio, M Martinello, M Law, ... Journal of hepatology 72 (4), 643-657, 2020 | 205 | 2020 |
| Epidemiology of hepatitis B, hepatitis C, and human immunodeficiency virus infections in patients with beta-thalassemia in Iran... SM Alavian, B Hajarizadeh, M javad Zahedi, V Zand Archives of Iranian medicine 9 (4), 319-323, 2006 | 202 | 2006 |
| Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study J Grebely, FMJ Lamoury, B Hajarizadeh, Y Mowat, AD Marshall, S Bajis, ... The lancet Gastroenterology & hepatology 2 (7), 514-520, 2017 | 190 | 2017 |
| Direct-acting antiviral agents for HCV infection affecting people who inject drugs J Grebely, B Hajarizadeh, GJ Dore Nature reviews Gastroenterology & hepatology 14 (11), 641-651, 2017 | 177 | 2017 |
| Evaluation of the Xpert HCV viral load finger-stick point-of-care assay FMJ Lamoury, S Bajis, B Hajarizadeh, AD Marshall, M Martinello, ... The Journal of infectious diseases 217 (12), 1889-1896, 2018 | 143 | 2018 |
| Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review S Colledge-Frisby, S Ottaviano, P Webb, J Grebely, A Wheeler, ... The Lancet Global Health 11 (5), e673-e683, 2023 | 140 | 2023 |
| Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis EB Cunningham, A Wheeler, B Hajarizadeh, CE French, R Roche, ... The lancet Gastroenterology & hepatology 7 (5), 426-445, 2022 | 139 | 2022 |
| Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection—the InC3 Study R Sacks-Davis, InC3 study group, J Grebely, InC3 Study Group, GJ Dore, ... The Journal of infectious diseases 212 (9), 1407-1419, 2015 | 124 | 2015 |
Jason GrebelyProfessor, The Kirby Institute, UNSW SydneyVerified email at kirby.unsw.edu.au
